Generic Name and Formulations:
Griseofulvin 125mg, 250mg; ultramicrosize; scored tabs.
Pedinol Pharmacal, Inc.
Indications for GRIS-PEG:
Ringworm infections of the skin, scalp, and nails.
375mg daily as 1 or more divided doses; max 750mg daily.
<2 yrs: not recommended. 35-60lbs: 125–187.5mg daily. >60lbs: 187.5mg–375mg daily.
Porphyria. Hepatocellular failure. Pregnancy.
Continue therapy until infection is eradicated. Periodic monitoring of renal, hepatic, and hematopoietic functions. Discontinue if granulocytopenia occurs. Penicillin sensitivity. Avoid exposure to sunlight or UV light. Nursing mothers.
Antagonizes oral anticoagulants. Antagonized by barbiturates. May potentiate alcohol. Oral contraceptives may be less effective.
Oral thrush, GI distress, dizziness, confusion, peripheral neuritis, photosensitivity, granulocytopenia, leukopenia, proteinuria, lupus-like syndrome.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- Psychological Therapies May Help Older Adults With Chronic Pain
- Traumatic Brain Injury Linked to Increased Parkinson Disease Risk in Veterans
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics